Abenavoli L, Falalyeyeva T, Boccuto L,
Tsyryuk O, Kobyliak N. 2018. Obeticholic
Acid: A New Era in the Treatment of
Nonalcoholic Fatty Liver Disease.
Pharmaceuticals (Basel), 11: 104.
Adil M, Kandhare AD, Ghosh P, Venkata S,
Raygude KS, Bodhankar SL. 2016 .
Ameliorative effect of naringin in
acetaminophen-induced hepatic and renal
toxicity in laboratory rats: role of FXR and
KIM-1. Ren Fail, 38: 1007-1020.
Amin A, Hamza AA, Bajbouj K, Ashraf SS,
Daoud S. 2011. Saffron: a potential
candidate for a novel anticancer drug
against hepatocellular carcinoma.
Hepatology, 54: 857-867.
Aml F. Elgazar, Rezq AA, Bukhari HM. 2013.
Anti-Hyperglycemic Effect of Saffron
Extract in Alloxan-Induced Diabetic Rats.
Eur J Biol Sci, 5: 14-22.
Armstrong LE, Guo GL. 2017. Role of FXR in
Liver Inflammation during Nonalcoholic
Steatohepatitis. Curr Pharmacol Rep, 3:
92-100.
Chen L, Qi Y, Yang X. 2015. Neuroprotective
effects of crocin against oxidative stress
induced by ischemia/reperfusion injury in
rat retina. Ophthalmic Res, 54: 157-168.
D'Alessandro AM, Mancini A, Lizzi AR, De
Simone A, Marroccella CE, Gravina GL,
Tatone C, Festuccia C. 2013. Crocus
sativus stigma extract and its major
constituent crocin possess significant
antiproliferative properties against human
prostate cancer. Nutr Cancer, 65: 930-942.
Degirolamo C, Modica S, Vacca M, Di Tullio
G, Morgano A, D'Orazio A, Kannisto K,
Parini P, Moschetta A. 2015. Prevention of
spontaneous hepatocarcinogenesis in
farnesoid X receptor-null mice by
intestinal-specific farnesoid X receptor
reactivation. Hepatology, 61: 161-170.
Ebrahimi F, Aryaeian N, Pahlavani N, Abbasi
D, Hosseini AF, Fallah S, Moradi N,
Heydari I. 2019. The effect of saffron
(Crocus sativus L.) supplementation on
blood pressure, and renal and liver
function in patients with type 2 diabetes
mellitus: A double-blinded, randomized
clinical trial. Avicenna J Phytomed, 9:
322-333.
Erfanparast A, Tamaddonfard E, Taati M,
Dabbaghi M. 2015. Effects of crocin and
safranal, saffron constituents ,on the
formalin-induced orofacial pain in rats.
Avicenna J Phytomed, 5: 392-402.
Hosseini A, Mousavi SH, Ghanbari A,
Homaee Shandiz F, Raziee HR, Pezeshki
Rad M, Mousavi SH. 2015. Effect of
saffron on liver metastases in patients
suffering from cancers with liver
metastases: A randomized, double blind,
placebo-controlled clinical trial. Avicenna
J Phytomed, 5: 434-440.
Jnaneshwari S, Hemshekhar M, Santhosh MS,
Sunitha K, Thushara R, Thirunavukkarasu
C, Kemparaju K, Girish KS. 2013. Crocin,
a dietary colorant, mitigates
cyclophosphamide-induced organ toxicity
by modulating antioxidant status and
inflammatory cytokines. J Pharm
Pharmacol, 65: 604-614.
Khalili A, Fallah P, Hashemi SA, AhmadianAttari MM, Jamshidi V, Mazloom R,
Beikzadeh L, Bayat G. 2021. New
mechanistic insights into hepatoprotective
activity of milk thistle and chicory
quantified extract: The role of hepatic
Farnesoid-X activated receptors. Avicenna
J Phytomed, 11: 367-379.
Khorasany AR, Hosseinzadeh H. 2016.
Therapeutic effects of saffron (Crocus
sativus L.) in digestive disorders: a review.
Iran J Basic Med Sci, 19: 455-469.
Khurana S, Raufman JP, Pallone TL. 2011.
Bile acids regulate cardiovascular
function. Clin Transl Sci, 4: 210-218.
Liu N, Meng Z, Lou G, Zhou W, Wang X,
Zhang Y, Zhang L, Liu X, Yen Y, Lai L,
Forman BM, Xu Z, Xu R, Huang W. 2012.
Hepatocarcinogenesis in FXR-/- mice
mimics human HCC progression that
operates through HNF1alpha regulation of
FXR expression. Mol Endocrinol, 26: 775-
785.
Lozano P, Castellar MR, Simancas MJ, Iborra
JL. 1999. A quantitative high-performance
liquid chromatographic method to analyse
commercial saffron (Crocus sativus L.)
products. J Chromatogr A, 830: 477-483.
Manley S, Ding W. 2015. Role of farnesoid X
receptor and bile acids in alcoholic liver
Induction of hepatic FXR expression by saffron
AJP, Vol. 11, No. 6, Nov-Dec 2021 631
disease. Acta Pharmaceutica Sinica B, 5:
158-167.
Mashmoul M, Azlan A, Mohtarrudin N, Mohd
Yusof BN, Khaza'ai H, Khoo HE,
Farzadnia M, Boroushaki MT. 2016.
Protective effects of saffron extract and
crocin supplementation on fatty liver
tissue of high-fat diet-induced obese rats.
BMC Complement Altern Med, 16: 401.
Mashmoul M, Azlan A, Yusof BNM, Khaza'ai
H, Mohtarrudin N, Boroushaki MT. 2014.
Effects of saffron extract and crocin on
anthropometrical, nutritional and lipid
profile parameters of rats fed a high fat
diet. J Funct Foods, 8: 180-187.
Mehdizadeh R, Parizadeh MR, Khooei AR,
Mehri S, Hosseinzadeh H. 2013.
Cardioprotective effect of saffron extract
and safranal in isoproterenol-induced
myocardial infarction in wistar rats. Iran J
Basic Med Sci, 16: 56-63.
Mehri S, Abnous K, Mousavi SH, Shariaty
VM, Hosseinzadeh H. 2012.
Neuroprotective effect of crocin on
acrylamide-induced cytotoxicity in PC12
cells. Cell Mol Neurobiol, 32: 227-235.
Melnyk JP, Wang S, Marcone MF. 2010.
Chemical and biological properties of the
world's most expensive spice: Saffron.
Food Research International, 43: 1981-
1989.
Moossavi M, Hoshyar R, Hemmati M, Farahi
A, Javdani H. 2016. An invivo study on the
hepato-protective effects of Crocus
sativus, Ziziphus jujuba and Berberis
vulgaris against acute acetaminophen and
rifampicin-induced hepatotoxicity.
Clinical Phytoscience, 2: 16.
Omidi A, Riahinia N, Torbati MBM, Behdani
M-A. 2014. Hepatoprotective effect of
Crocus sativus (saffron) petals extract
against acetaminophen toxicity in male
Wistar rats. Avicenna J Phytomed, 4: 330-
336.
Prawitt J, Caron S, Staels B. 2011. Bile acid
metabolism and the pathogenesis of type 2
diabetes. Curr Diab Rep, 11: 160-166.
Purushothuman S, Nandasena C, Peoples CL,
El Massri N, Johnstone DM, Mitrofanis J,
Stone J. 2013. Saffron pre-treatment offers
neuroprotection to Nigral and retinal
dopaminergic cells of MPTP-Treated
mice. J Parkinsons Dis, 3: 77-83.
Safari F, Anvari Z, Moshtaghioun S, Javan M,
Bayat G, Forosh SS, Hekmatimoghaddam
S. 2014. Differential expression of cardiac
uncoupling proteins 2 and 3 in response to
myocardial ischemia-reperfusion in rats.
Life Sci, 98: 68-74.
Safari F, Hajiadeh S, Moshtaghion SH,
Forouzandeh Moghadam M,
Shekarforoush S, Bayat G, Mazlum R,
Sattarian L. 2012. Effect of losartan on
NOX2 transcription following acute
myocardial ischemia-reperfusion. PhysiolPharmacol, 16: 44-53.
Schmitt J, Kong B, Stieger B, Tschopp O,
Schultze SM, Rau M, Weber A, Mullhaupt
B, Guo GL, Geier A. 2015. Protective
effects of farnesoid X receptor (FXR) on
hepatic lipid accumulation are mediated by
hepatic FXR and independent of intestinal
FGF15 signal. Liver Int, 35: 1133-1144.
Shapiro H, Kolodziejczyk AA, Halstuch D,
Elinav E. 2018. Bile acids in glucose
metabolism in health and disease. J Exp
Med, 215: 383-396.
Su H, Ma C, Liu J, Li N, Gao M, Huang A,
Wang X, Huang W, Huang X. 2012.
Downregulation of nuclear receptor FXR
is associated with multiple malignant
clinicopathological characteristics in
human hepatocellular carcinoma. Am J
Physiol Gastrointest Liver Physiol, 303:
G1245-1253.
Venkatesan PS, Deecaraman M,
Vijayalakshmi M, Sakthivelan SM. 2014.
Sub-acute toxicity studies of
acetaminophen in Sprague Dawley rats.
Biol Pharm Bull, 37: 1184-1190.
Verbeke L, Mannaerts I, Schierwagen R,
Govaere O, Klein S, Vander Elst I,
Windmolders P, Farre R, Wenes M,
Mazzone M, Nevens F, van Grunsven LA,
Trebicka J, Laleman W. 2016. FXR
agonist obeticholic acid reduces hepatic
inflammation and fibrosis in a rat model of
toxic cirrhosis. Sci Rep, 6: 33453.
Wang YD, Chen WD, Wang M, Yu D, Forman
BM, Huang W. 2008. Farnesoid X
receptor antagonizes nuclear factor
kappaB in hepatic inflammatory response.
Hepatology, 48: 1632-1643.
Yarijani ZM, Pourmotabbed A, Pourmotabbed
T, Najafi H. 2017. Crocin has antiinflammatory and protective effects in
ischemia-reperfusion induced renal
injuries. Iran J Basic Med Sci, 20: 753-
759.
Jamshidi et al.
AJP, Vol. 11, No. 6, Nov-Dec 2021 632
Zhang S, Wang J, Liu Q, Harnish DC. 2009.
Farnesoid X receptor agonist WAY362450 attenuates liver inflammation and
fibrosis in murine model of non-alcoholic
steatohepatitis. J Hepatol, 51: 380-388.
Zhu C, Fuchs CD, Halilbasic E, Trauner M.
2016. Bile acids in regulation of
inflammation and immunity :friend or foe?
Clin Exp Rheumatol, 34: 25-31.